News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
327 Results
Type
Article (30)
Company Profile (1)
Press Release (296)
Section
Business (118)
Career Advice (1)
Deals (25)
Drug Development (30)
FDA (11)
Job Trends (6)
News (168)
Policy (10)
Tag
Alliances (17)
Alzheimer's disease (1)
Approvals (14)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (3)
Cancer (1)
Cardiovascular disease (3)
Clinical research (33)
Collaboration (4)
COVID-19 (2)
C-suite (3)
Cystic fibrosis (1)
Data (10)
Duchenne muscular dystrophy (3)
Earnings (72)
Events (66)
Executive appointments (3)
FDA (17)
Funding (1)
GLP-1 (1)
Government (2)
Guidances (2)
Infectious disease (2)
Inflammatory bowel disease (1)
Intellectual property (3)
IPO (16)
Labor market (1)
Layoffs (2)
Manufacturing (2)
Medical device (1)
Medtech (1)
Mergers & acquisitions (11)
Metabolic disorders (1)
Neurodegenerative disease (1)
Neuroscience (2)
Now hiring (1)
Obesity (1)
Patient recruitment (1)
People (37)
Pharmaceutical (1)
Phase 1 (5)
Phase 2 (7)
Phase 3 (23)
Pipeline (18)
Rare diseases (1)
Real estate (1)
Regulatory (15)
Startups (6)
Venture capital (1)
Women's health (1)
Date
Last 7 days (1)
Last 30 days (8)
Last 365 days (52)
2026 (13)
2025 (43)
2024 (62)
2023 (49)
2022 (49)
2021 (46)
2020 (35)
2019 (11)
2018 (4)
2017 (15)
Location
Asia (34)
Australia (1)
California (9)
Canada (1)
China (2)
Europe (126)
Japan (15)
Massachusetts (1)
New Jersey (1)
New York (1)
Northern California (3)
Pennsylvania (5)
South America (1)
Southern California (8)
Texas (1)
United States (18)
327 Results for "Idorsia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Global expansion of Idorsia’s QUVIVIQ continues with EMS partnership for Latin America
January 28, 2026
·
6 min read
Press Releases
Idorsia’s JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
January 5, 2026
·
8 min read
Press Releases
Idorsia’s daridorexant in women during menopausal transition age with insomnia
January 6, 2026
·
12 min read
Press Releases
Nature Communications reports promising effect of Idorsia’s lucerastat on kidney function in Fabry disease
January 12, 2026
·
11 min read
Press Releases
Idorsia to present at J.P. Morgan 2026 Healthcare Conference
January 12, 2026
·
4 min read
Press Releases
Idorsia to present long-term lucerastat data and kidney biopsy results at WORLDSymposium
January 30, 2026
·
9 min read
Press Releases
Idorsia’s aprocitentan improved key prognostic indicators in patients with difficult-to-control hypertension
November 10, 2025
·
17 min read
Press Releases
Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China
September 22, 2025
·
6 min read
Press Releases
Idorsia’s JERAYGO (aprocitentan) approved in Switzerland for the treatment of resistant hypertension
September 19, 2025
·
9 min read
Press Releases
Idorsia initiates a proof-of-concept trial with its oral first-in-class selective CCR6 antagonist
January 6, 2026
·
10 min read
1 of 33
Next
